Effects of flaxseed and flax oil diets in a rat-5/6 renal ablation model.

[1]  W. Clark,et al.  Abrogation of MRL/lpr lupus nephritis by dietary flaxseed. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  W. Clark,et al.  Omega-3 fatty acid supplementation in primary nephrotic syndrome: effects on plasma lipids and coagulopathy. , 1992, Journal of the American Society of Nephrology : JASN.

[3]  T. Pm,et al.  Clinical strategies for arresting progression of renal disease. , 1992 .

[4]  W. Ratnayake,et al.  Chemical and nutritional studies of flaxseed (variety Linott) in rats , 1992 .

[5]  L. Thompson,et al.  Flaxseed supplementation and early markers of colon carcinogenesis. , 1992, Cancer letters.

[6]  T. Hamazaki,et al.  Comparison of the conversion rates of alpha-linolenic acid (18:3(n - 3)) and stearidonic acid (18:4(n - 3)) to longer polyunsaturated fatty acids in rats. , 1992, Biochimica et biophysica acta.

[7]  S. Cunnane,et al.  Alpha-linolenic acid in humans: direct functional role or dietary precursor? , 1991, Nutrition.

[8]  S. Klahr Chronic renal failure: management , 1991, The Lancet.

[9]  Harry E. Jacobson Chronic renal failure: pathophysiology , 1991, The Lancet.

[10]  J. Trosko,et al.  Inhibition of gap junction-mediated intercellular communication by alpha-linolenate. , 1991, The American journal of physiology.

[11]  N. Perico,et al.  Platelet-activating factor alters glomerular barrier size selectivity for macromolecules in rats. , 1991, The American journal of physiology.

[12]  W. Clark,et al.  Chronic effects of omega-3 fatty acids (fish oil) in a rat 5/6 renal ablation model. , 1991, Journal of the American Society of Nephrology : JASN.

[13]  B. McDonald,et al.  Dietary alpha-linolenic acid is as effective as oleic acid and linoleic acid in lowering blood cholesterol in normolipidemic men. , 1991, The American journal of clinical nutrition.

[14]  E. Baldi,et al.  Platelet activating factor receptor blockade ameliorates murine systemic lupus erythematosus. , 1990, Kidney international.

[15]  N. Perico,et al.  Thromboxane synthesis inhibition increases renal prostacyclin and prevents renal disease progression in rats with remnant kidney. , 1990, Journal of the American Society of Nephrology : JASN.

[16]  W. Jaeger,et al.  Effects of dietary oleic, linoleic and alpha-linolenic acids on blood pressure, serum lipids, lipoproteins and the formation of eicosanoid precursors in patients with mild essential hypertension. , 1990, Journal of human hypertension.

[17]  W. Clark,et al.  Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus. , 1989, Kidney international.

[18]  H. Gröne,et al.  Induction of glomerulosclerosis by dietary lipids. A functional and morphologic study in the rat. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[19]  S. Klahr,et al.  Effect of heparin on the glomerular structure and function of remnant nephrons. , 1988, Kidney international.

[20]  P. Kris-Etherton,et al.  The effect of diet on plasma lipids, lipoproteins, and coronary heart disease. , 1988, Journal of the American Dietetic Association.

[21]  P. Weber,et al.  Cardiovascular effects of N-3 fatty acids. , 1988, Journal of nutritional science and vitaminology.

[22]  B. Kasiske,et al.  Pharmacologic Treatment of Hyperlipidemia Reduces Glomerular Injury in Rat 5/6 Nephrectomy Model of Chronic Renal Failure , 1988, Circulation research.

[23]  S. Klahr,et al.  Factors that may retard the progression of renal disease. , 1987, Kidney international. Supplement.

[24]  G. Camussi,et al.  Receptor antagonist of platelet activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin. , 1987, The Journal of laboratory and clinical medicine.

[25]  T. Hostetter,et al.  Dietary protein restriction in established renal injury in the rat. Selective role of glomerular capillary pressure in progressive glomerular dysfunction. , 1986, The Journal of clinical investigation.

[26]  B. Brenner Nephron adaptation to renal injury or ablation. , 1985, The American journal of physiology.

[27]  B. Brenner,et al.  Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. , 1985, The Journal of clinical investigation.

[28]  J. Jobin,et al.  Measurement of glomerular filtration rate in conscious unrestrained rats with inulin infused by implanted osmotic pumps. , 1985, The American journal of physiology.

[29]  B. Brenner,et al.  Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. , 1982, The New England journal of medicine.

[30]  G. Camussi,et al.  Release of platelet-activating factor in human pathology. I. Evidence for the occurrence of basophil degranulation and release of platelet-activating factor in systemic lupus erythematosus. , 1981, Laboratory investigation; a journal of technical methods and pathology.

[31]  S. Klahr,et al.  Pathogenesis of the glomerulopathy associated with renal infarction in rats. , 1976, Kidney international.

[32]  T. Shimamura,et al.  A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats. , 1975, The American journal of pathology.

[33]  A. Chanutin,et al.  EXPERIMENTAL RENAL INSUFFICIENCY PRODUCED BY PARTIAL NEPHRECTOMY , 1939 .

[34]  A. Chanutin,et al.  EXPERIMENTAL RENAL INSUFFICIENCY PRODUCED BY PARTIAL NEPHRECTOMY: I. CONTROL DIET , 1932 .

[35]  J. Bradford The results following partial Nephrectomy and the influence of the Kidney on Metabolism 1 , 1899, The Journal of physiology.

[36]  L. Thompson,et al.  Mammalian lignan production from various foods. , 1991, Nutrition and cancer.

[37]  山崎 勝也 Comparison of the conversion rates of α-linolenic acid [18:3n-3] and stearidonic acid [18:4n-3] to longer polyunsaturated fatty acids in rats , 1991 .

[38]  P. Taylor,et al.  Dietary alpha-linolenic acid and immunocompetence in humans. , 1991, The American journal of clinical nutrition.

[39]  J. L. Lerma,et al.  Involvement of lipid mediators in the pathogenesis of experimental nephrosis in rats: its pharmacological modulation. , 1991, Renal failure.

[40]  J. Gastwirth Non-parametric Statistical Methods , 1990 .

[41]  W. Clark,et al.  Comparative efficacy of dietary treatments on renal function in rats with sub-total nephrectomy: renal polyunsaturated fatty acid incorporation and prostaglandin excretion. , 1990, Clinical nephrology.

[42]  G. Camussi,et al.  Release of platelet-activating factor in systemic lupus erythematosus. , 1990, International archives of allergy and applied immunology.

[43]  L. D. Simpson Renal disease, polyunsaturated fatty acids and blood rheology. , 1986, Nephron.

[44]  S. Klahr,et al.  Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[45]  G. Camussi,et al.  Platelet-activating factor-induced loss of glomerular anionic charges. , 1984, Kidney international.

[46]  B. Brenner,et al.  Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. , 1983, Kidney international.

[47]  B. Brenner,et al.  Hyperfiltration in remnant nephrons , 1981 .

[48]  J. Hayslett Functional adaptation to reduction in renal mass. , 1979, Physiological reviews.